Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE · · 2 pages · English
Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Jun 27 2025
- Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements Requirements) Regulations, 2015.
- Vista Pharmaceuticals Ltd. Press Release Jun 26 2025
- Closure of Trading Window
- Vista Pharmaceuticals Ltd. Press Release May 30 2025
Later from Vista Pharmaceuticals
- Outcome Of Circular Resolution Passed By Board Of Directors Of The Company By Circulation On July 16, 2025 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Vista Pharmaceuticals Ltd. Press Release Jul 16 2025
- Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30.06.2025
- Vista Pharmaceuticals Ltd. Press Release Aug 06 2025
- Results - Unaudited Financial Results For The Quarter Ended 30.06.2025
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals